Access to Non-Summary Clinical Trial Data for Research Purposes Under EU Law
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 1 Introduction
-
Altmetric BadgeChapter 2 The Context and the Problem
-
Altmetric BadgeChapter 3 Secondary Analysis of Individual Patient-Level Clinical Trial Data: A Primer
-
Altmetric BadgeChapter 4 Legal Sources of Control Over and Access to Clinical Trial Data Under the EU Applicable Framework
-
Altmetric BadgeChapter 5 Implications of IPD Disclosure for Statutory Innovation Incentives
-
Altmetric BadgeChapter 6 Defining the Intervention Logic of Access-To-Data Measures: A Problem Analysis
-
Altmetric BadgeChapter 7 Access to Clinical Trial Data as a Case on R&D Externalities: A Theoretical Framework
-
Altmetric BadgeChapter 8 IPD as a Research Resource: Exclusively Controlled or Readily Accessible?
-
Altmetric BadgeChapter 9 Evaluating Legislative Options
-
Altmetric BadgeChapter 10 Final Conclusions and the Outlook
Altmetric Badge
Citations
- dimensions_citation
- 3 Dimensions
